Mingmei Du1, Linjian Song2, Yan Wang3, Jijiang Suo1, Yanling Bai1, Yubin Xing1, Lijun Xie1, Bowei Liu1, Lu Li1, Yanping Luo4, Yunxi Liu5. 1. Department of Disease Prevention and Control, First Medical Center of Chinese PLA General Hospital, Beijing, China. 2. Center for Clinical Laboratory Medicine, First Medical Center of Chinese PLA General Hospital, Beijing, China. 3. Department of Urology, First Medical Center of Chinese PLA General Hospital, Beijing, China. 4. Center for Clinical Laboratory Medicine, First Medical Center of Chinese PLA General Hospital, Beijing, China. ypluo301@aliyun.com. 5. Department of Disease Prevention and Control, First Medical Center of Chinese PLA General Hospital, Beijing, China. liuyunxi301@qq.com.
Abstract
BACKGROUND: This report describes an outbreak of 71 patients developed B. cepacia urinary tract infection (UTI) by contaminated single-use anesthetic gel. METHODS: Epidemiological investigation of patients with B. cepacia-positive urine or blood samples between March 19, 2018 and Novemeber 15, 2018 was conducted to identify the source of infection. Microbiological samples from hospital surfaces, endoscopes, disposable items, and the hands of staff were tested for B. cepacia contamination. Pulsed-field gel electrophoresis (PFGE) was used to compare homology in B. cepacia isolates. RESULTS: During the outbreak, nosocomial B. cepacia UTI was confirmed in 71 patients. Epidemiological investigation showed that 66 patients underwent invasive urological diagnosis and treatment, while the remaining five patients underwent bedside indwelling catheterization, with all patients exposed to single-use anesthetic gel. All batches of anesthetic gel were recalled and the outbreak abated. Overall, 155 samples were collected from environmental surfaces and disposable items, and B. cepacia contamination was confirmed in samples from one used cystoscope and three anesthetic gels from the same batch. PFGE showed homology between 17 out of 20 B. cepacia isolates from patients and three isolates from the contaminated anesthetic gel. All patients achieved cure. CONCLUSION: Contaminated single-use anesthetic gel was confirmed as the source of the B. cepacia outbreak, with infection occurring during invasive urological diagnostic and treatments. Thus, investigations of nosocomial outbreaks of B. cepacia infection should consider contamination of diagnostic and treatment items used in infected patients.
BACKGROUND: This report describes an outbreak of 71 patients developed B. cepacia urinary tract infection (UTI) by contaminated single-use anesthetic gel. METHODS: Epidemiological investigation of patients with B. cepacia-positive urine or blood samples between March 19, 2018 and Novemeber 15, 2018 was conducted to identify the source of infection. Microbiological samples from hospital surfaces, endoscopes, disposable items, and the hands of staff were tested for B. cepacia contamination. Pulsed-field gel electrophoresis (PFGE) was used to compare homology in B. cepacia isolates. RESULTS: During the outbreak, nosocomial B. cepaciaUTI was confirmed in 71 patients. Epidemiological investigation showed that 66 patients underwent invasive urological diagnosis and treatment, while the remaining five patients underwent bedside indwelling catheterization, with all patients exposed to single-use anesthetic gel. All batches of anesthetic gel were recalled and the outbreak abated. Overall, 155 samples were collected from environmental surfaces and disposable items, and B. cepacia contamination was confirmed in samples from one used cystoscope and three anesthetic gels from the same batch. PFGE showed homology between 17 out of 20 B. cepacia isolates from patients and three isolates from the contaminated anesthetic gel. All patients achieved cure. CONCLUSION: Contaminated single-use anesthetic gel was confirmed as the source of the B. cepacia outbreak, with infection occurring during invasive urological diagnostic and treatments. Thus, investigations of nosocomial outbreaks of B. cepacia infection should consider contamination of diagnostic and treatment items used in infectedpatients.
Entities:
Keywords:
B. cepacia; Outbreak; Urinary tract infection
Authors: Ramon Z Shaban; Samuel Maloney; John Gerrard; Peter Collignon; Deborough Macbeth; Marilyn Cruickshank; Anna Hume; Amy V Jennison; Rikki M A Graham; Haakon Bergh; Heather L Wilson; Petra Derrington Journal: Am J Infect Control Date: 2017-07-27 Impact factor: 2.918
Authors: Lucila Marquez; Katie N Jones; Elaine M Whaley; Tjin H Koy; Paula A Revell; Ruston S Taylor; M Brooke Bernhardt; Jeffrey L Wagner; James J Dunn; John J LiPuma; Judith R Campbell Journal: Infect Control Hosp Epidemiol Date: 2017-02-07 Impact factor: 3.254
Authors: Preeta K Kutty; Barbara Moody; Jessica Smartt Gullion; Marcus Zervos; Marie Ajluni; Rebecca Washburn; Roger Sanderson; Marion A Kainer; Timothy A Powell; Carmen F Clarke; Renee J Powell; Neil Pascoe; Alicia Shams; John J LiPuma; Bette Jensen; Judith Noble-Wang; Matthew J Arduino; L Clifford McDonald Journal: Chest Date: 2007-10-09 Impact factor: 9.410
Authors: Saad Alhumaid; Abbas Al Mutair; Zainab Al Alawi; Abeer M Alshawi; Salamah A Alomran; Mohammed S Almuhanna; Anwar A Almuslim; Ahmed H Bu Shafia; Abdullah M Alotaibi; Gasmelseed Y Ahmed; Ali A Rabaan; Jaffar A Al-Tawfiq; Awad Al-Omari Journal: Pathogens Date: 2021-06-25